Aptose Biosciences
APTO
#10372
Rank
S$5.58 M
Marketcap
S$2.19
Share price
0.00%
Change (1 day)
-44.87%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -S$27.81 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$32.29 Million, an increase over its 2023 earnings that were of -S$67.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$27.81 Million-13.9%
2024 -S$32.29 Million-51.82%
2023 -S$67.03 Million22.9%
2022 -S$54.54 Million-34.91%
2021 -S$83.79 Million17.36%
2020 -S$71.4 Million107.65%
2019 -S$34.39 Million-7.73%
2018 -S$37.27 Million160.68%
2017 -S$14.3 Million-20.27%
2016 -S$17.93 Million28.71%
2015 -S$13.93 Million
2013 -S$7.9 Million
2010 -S$6.73 Million-8.31%
2009 -S$7.34 Million
2006 -S$13.6 Million-156.93%
2005 S$23.88 M-185.16%
2004 -S$28.05 Million458.58%
2003 -S$5.03 Million-63.66%
2002 -S$13.82 Million-8.04%
2001 -S$15.03 Million16.73%
2000 -S$12.88 Million294.99%
1999 -S$3.26 Million-6.51%
1998 -S$3.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-S$80.37 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-S$86.43 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-S$43.56 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA